LOCUS AK308071 1461 bp mRNA linear HTC 12-JAN-2008
DEFINITION Homo sapiens cDNA, FLJ98019.
ACCESSION AK308071
VERSION AK308071.1
KEYWORDS HTC; HTC_FLI; oligo capping.
SOURCE Homo sapiens (human)
ORGANISM Homo sapiens
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
REFERENCE 1 (bases 1 to 1461)
AUTHORS Isogai,T. and Yamamoto,J.
TITLE Direct Submission
JOURNAL Submitted (11-JAN-2008) to the DDBJ/EMBL/GenBank databases.
Contact:Takao Isogai
Reverse Proteomics Research Institute; 1-9-11 Kaji-cho,
Chiyoda-ku, Tokyo 101-0044, Japan
E-mail :flj-cdna@nifty.com
REFERENCE 2
AUTHORS Wakamatsu,A., Yamamoto,J., Kimura,K., Ishii,S., Watanabe,K.,
Sugiyama,A., Murakawa,K., Kaida,T., Tsuchiya,K., Fukuzumi,Y.,
Kumagai,A., Oishi,Y., Yamamoto,S., Ono,Y., Komori,Y., Yamazaki,M.,
Kisu,Y., Nishikawa,T., Sugano,S., Nomura,N. and Isogai,T.
TITLE NEDO human cDNA sequencing project
JOURNAL Unpublished (2008)
COMMENT Human cDNA sequencing project focused on splicing variants of mRNA
in NEDO functional analysis of protein and research application
project supported by Ministry of Economy, Trade and Industry,
Japan; cDNA selection for complete cds sequencing: Reverse
Proteomics Research Institute (REPRORI), Hitachi, Ltd., Japan
(Hitachi) and Japan Biological Informatics Consortium, Japan
(JBIC); cDNA complete cds sequencing: JBIC; cDNA library
construction: Helix Research Institute supported by Japan Key
Technology Center, Japan (HRI); cDNA 5'- & 3'-end sequencing:
Research Association for Biotechnology, Japan, Biotechnology
Center, National Institute of Technology and Evaluation, Japan and
HRI; cDNA mapping to human genome: Central Research Laboratory,
Hitachi; evaluation and annotation: REPRORI.
FEATURES Location/Qualifiers
source 1..1461
/cell_line="NT2"
/cell_type="teratocarcinoma"
/clone="NT2RI2026914"
/clone_lib="NT2RI2"
/db_xref="H-InvDB:HIT000426937"
/db_xref="taxon:9606"
/mol_type="mRNA"
/note="cloning vector: pME18SFL3"
/note="mRNA from NT2 neuronal precursor cells treated
2-weeks mitotic inhibitor after 5-weeks retinoic acid
(RA) induction."
/note="majorly NT2 neuron"
/organism="Homo sapiens"
BASE COUNT 422 a 297 c 309 g 433 t
ORIGIN
1 aatcagctca gcgaagccgc cgcagaggct gatggggggc tggaggctgt gaggcttcca
61 gcgtcggccc agaccttctc tttccctttc cagcagccgg agaagtgcga caacaaccag
121 tactttgata tctccgccct ctcgtgtgtt ccttgtggag ctaaccagag gcaagatgcc
181 cgaggaactt catgtgtatg tctaccagga tttcagatga tctctaataa tggaggacct
241 gctattattt gtaaaaagtg cccagaaaac atgaaaggtg ttacagaaga tggctggaac
301 tgcatttctt gccctagtga cttaactgcc gaaggaaaat gtcactgtcc cattggccat
361 attttagtgg aaagagacat taatggaaca ttgttgtctc aagcaacttg tgagctctgt
421 gatggaaatg aaaactcttt tatggtagta aatgctttag gagacaggtg cgtccgatgt
481 gagccaacat ttgttaatac cagcaggtcc tgtgcatgtt cagaacctaa cattttaaca
541 gggggattat gtttcagcag cacagggaat tttcctctac gtagaatttc agctgcacgt
601 tatggagaag ttggcatgtc tttaacttca gaatggtttg caaagtattt gcaatcatca
661 gcagctgcat gttgggtata tgccaatcta acatcttgtc aagctcttgg aaatatgtgt
721 gtgatgaaca tgaattctta cgactttgcc acatttgatg catgtggact atttcagttt
781 atctttgaaa atactgctgg actgagcact gttcattcta tttcattttg gagacagaat
841 cttccttggc tgttttatgg agaccagtta ggattagcac ctcaagtgct cagttctacc
901 tctcttccta caaatttcag ttttaaagga gaaaaccaga atacaaaact gaagtttgtt
961 gctgcttcct atgatataag aggaaatttt ctcaagtggc aaactttaga aggaggtgtt
1021 ttacagcttt gtccagacac agagacaagg ctaaatgctg cttattcatt tggaacaacc
1081 taccaacaaa attgtgagat tcctatctct aagatcttaa ttgactttcc cactcctata
1141 ttttatgatg tgtaccttga atatactgat gaaaatcaac atcaatatat tttggctgtg
1201 cctgtgttaa acctaaatct tcaacataat aagatatttg tgaaccaaga cagcaacact
1261 ggaaagtggc ttctaactcg gcgcattttc ttagtggatg cagtaagtgg acgagaaaat
1321 gacttaggaa ctcagccaag agtaattcga gttgctactc aaatatcact gagtgtccac
1381 cttgtaccca acacaataaa tggaaacatc tagcctccct taatcaccat tgcctacagt
1441 gacattgata tcaaagatgc c
//